AI Generated
Oct 9, 2026, 11:29
Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
Jigesha Dholakia, Director of CMC Analytical Strategy at Bayer, shared a post on LinkedIn։
”I will be participating in the Unite Walk on November 7th in Walnut Creek, CA to support patients with the hemophilia disease, representing Bayer.
This foundation is very near to me, as I have been participating in these walks for a decade now, starting with BioMarin, where I was working on the gene therapy, Roctavian for hemophilia; and now where I work at Bayer who manufactures the hemophilia drugs Jivi and Covaltry.
Bayer Please support my cause by donating at this link.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT